These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29100717)

  • 1. Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus.
    Kalirai S; Stephenson J; Perez-Nieves M; Grabner M; Hadjiyianni I; Geremakis C; Pollom RD; Reed B; Fisher L
    Prim Care Diabetes; 2018 Apr; 12(2):155-162. PubMed ID: 29100717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.
    Galasso S; Facchinetti A; Bonora BM; Mariano V; Boscari F; Cipponeri E; Maran A; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1112-1119. PubMed ID: 27618501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin initiation status of primary care physicians in Turkey, barriers to insulin initiation and knowledge levels about insulin therapy: A multicenter cross-sectional study.
    Ates E; Set T; Saglam Z; Tekin N; Karatas Eray I; Yavuz E; Sahin MK; Selcuk EB; Cadirci D; Cubukcu M
    Prim Care Diabetes; 2017 Oct; 11(5):430-436. PubMed ID: 28579057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care.
    Kostev K; Dippel FW; Rathmann W
    Prim Care Diabetes; 2016 Apr; 10(2):142-7. PubMed ID: 26324105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
    Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
    Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
    Zhang T; Lin M; Li W; Fan X; Du T; Zhao Y; Zhang X
    Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients.
    Cander S; Oz Gul O; Dizdar OS; Koca N; Aydın T; Sarandol E; Ersoy C
    Metab Syndr Relat Disord; 2017 Jun; 15(5):220-225. PubMed ID: 28394183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.
    Bonadonna RC; Giaccari A; Buzzetti R; Aimaretti G; Cucinotta D; Avogaro A; Perseghin G; Larosa M; Bolli GB; Fanelli CG
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):496-503. PubMed ID: 30952575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study.
    Hafez D; Nelson DB; Martin EG; Cohen AJ; Northway R; Kullgren JT
    BMC Fam Pract; 2017 Apr; 18(1):50. PubMed ID: 28376802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey.
    Cuddihy RM; Philis-Tsimikas A; Nazeri A
    Diabetes Educ; 2011; 37(1):111-23. PubMed ID: 21131599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes.
    Hayes RP; Fitzgerald JT; Jacober SJ
    Int J Clin Pract; 2008 Jun; 62(6):860-8. PubMed ID: 18393965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.
    Demma LJ; Carlson KT; Duggan EW; Morrow JG; Umpierrez G
    J Clin Anesth; 2017 Feb; 36():184-188. PubMed ID: 28183563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated primary and specialty care for type 2 diabetes mellitus, guidelines, and systems: an educational needs assessment.
    Beaser RS; Okeke E; Neighbours J; Brown J; Ronk K; Wolyniec WW
    Endocr Pract; 2011; 17(6):880-90. PubMed ID: 21550953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A changed pattern of insulin use following the introduction of basal analog insulin treatment in primary care.
    Heymann AD; Kritz V; Hemo B; Kertes J; Becker M
    Prim Care Diabetes; 2013 Apr; 7(1):57-61. PubMed ID: 23352415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
    Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
    Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
    Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors.
    Zhang T; Ji L; Gao Y; Zhang P; Zhu D; Li X; Ji J; Zhao F; Zhang H; Guo X
    Diabetes Technol Ther; 2017 Nov; 19(11):675-684. PubMed ID: 29090977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
    Khunti K; Millar-Jones D
    Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial.
    Davies MJ; Russell-Jones D; Selam JL; Bailey TS; Kerényi Z; Luo J; Bue-Valleskey J; Iványi T; Hartman ML; Jacobson JG; Jacober SJ;
    Diabetes Obes Metab; 2016 Nov; 18(11):1055-1064. PubMed ID: 27349219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.